Study: hydroxychloroquine can boost COVID-19 survival chances by nearly 200%

OAN Newsroom
UPDATED 6:45 PM PT – Tuesday, June 8, 2021

Another study has confirmed hydroxychloroquine to be effective in the treatment of COVID-19. Conducted by the Saint Barnabas Medical Center, the research has found the combination of hydroxychloroquine and antibiotic Zithromax effectively suppresses COVID-19.

The study has suggested this treatment can increase survival chances by nearly 200 percent if given at high doses in mechanically ventilated patients with severe COVID-19 illness. Scientists also reported that higher doses of hydroxychloroquine led to a quicker recovery in 87-percent of observed patients.

This comes after public health experts, including Dr. Anthony Fauci, have denied the effectiveness of hydroxychloroquine in treating COVID-19. Biological weapons expert, Dr. Steven Hatfill, has pointed blame at these experts for the hundreds of thousands of American deaths that resulted from the pandemic.

“It was false,” he asserted. “They didn’t want competition for the vaccines.”

The study also found hydroxychloroquine is particularly efficient in terminally ill patients who would otherwise have died without that drug.

MORE NEWS: Oxford Study Reports No Bats Or Pangolins Were Sold In The Wuhan Wet Market

*As an Amazon Associate I earn from qualifying purchases